Understanding Your CLL Prognosis: Your Path to Personalised Treatment
Receiving a Chronic Lymphocytic Leukaemia diagnosis can feel overwhelming, but knowing your specific prognosis transforms uncertainty into actionable information. Our comprehensive CLL Prognostic Panel provides the clarity you need to work with your healthcare team in developing the most effective treatment strategy for your unique situation.
What This Test Reveals About Your Leukaemia
This advanced diagnostic panel examines multiple genetic markers that influence how your CLL behaves and responds to treatment. By analysing specific proteins and chromosomal changes, we can predict whether your leukaemia is likely to progress slowly or rapidly, and which treatments will be most effective for your specific genetic profile.
Key Markers We Analyse:
- ZAP-70 & CD38: Indicators of how aggressive your leukaemia cells are
- IGVH Mutation Status: Determines if you have better or poorer prognosis
- Chromosomal Abnormalities: Identifies specific genetic changes affecting treatment response
- TP53 & ATM Deletions: Critical for understanding resistance to certain therapies
Who Should Consider This Prognostic Testing?
If you’ve been diagnosed with CLL or are experiencing concerning symptoms, this panel provides essential information for your treatment journey. Many South African patients in Johannesburg, Cape Town, and Durban have found this testing crucial for:
- Newly diagnosed CLL patients seeking personalised treatment plans
- Patients experiencing unexplained fatigue, weight loss, or frequent infections
- Individuals with enlarged lymph nodes or spleen
- Those needing to understand if their CLL requires immediate treatment
- Patients considering participation in clinical trials
Why This Matters for Your Health Journey
Understanding your CLL prognosis isn’t just about information—it’s about empowerment. This testing provides:
- Personalised Treatment Planning: Match therapies to your genetic profile for better outcomes
- Avoid Unnecessary Treatment: Identify if watchful waiting is appropriate
- Predict Disease Progression: Understand if your CLL is likely to remain stable or progress rapidly
- Treatment Response Prediction: Know which therapies will work best for your specific leukaemia
- Peace of Mind: Replace uncertainty with clear, actionable information
Understanding Your Results: Clear Guidance Every Step
We know waiting for results can be anxiety-provoking. Our comprehensive report provides clear explanations in language you can understand, with:
- Detailed breakdown of each genetic marker and what it means for your prognosis
- Clear risk categorisation (low, intermediate, or high risk)
- Specific treatment recommendations based on your genetic profile
- Direct consultation with our haematology specialists to discuss your results
- Ongoing support for questions about your report
Transparent Pricing & Exceptional Value
| Service | Regular Price | Special Price | Savings |
|---|---|---|---|
| CLL Prognostic Panel | ZAR 10,000 | ZAR 7,700 | ZAR 2,300 |
Turnaround Time: Sample received Monday by 9 AM; Report delivered following Monday
Sample Requirements: Blood sample from lavender top EDTA tube OR bone marrow sample with completed Form 17
Why South Africans Trust Oracle Genomics
- Nationwide Coverage: Serving patients across Johannesburg, Cape Town, Durban, Pretoria and beyond
- Specialised Expertise: Working exclusively with haematologists and oncologists
- Advanced Technology: Using PCR sequencing, FISH analysis, and flow cytometry for maximum accuracy
- Rapid Results: Consistent one-week turnaround for timely treatment decisions
- Patient-Focused Care: Clear communication and ongoing support throughout your journey
Take Control of Your CLL Journey Today
Don’t let uncertainty dictate your treatment path. With our comprehensive prognostic panel, you gain the knowledge needed to make informed decisions with your healthcare team.
Limited Time Offer: Secure your ZAR 7,700 pricing while available. Early prognosis understanding can significantly impact your treatment success and quality of life.
“The clarity from this testing gave me confidence in my treatment decisions and peace of mind about my journey ahead.” – Recent Oracle Genomics Patient
